Q32 Bio Inc.
QTTBNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for QTTB. That does not mean none is planned.
Get an email about QTTB's next catalysts
Track Q32 Bio (QTTB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
QTTB Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.36 | FQ end Sep/2026 | Call: tbd
How QTTB's past catalysts played out
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
bempikibart (ADX-914) | Phase 2 | Alopecia Areata | - | - |
ADX-914 | Phase 2 | Atopic Dermatitis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Q32 Bio Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Q32 Bio Inc.'s (QTTB) pipeline across Phase 2. Its lead program is ADX-914 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Q32 Bio Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Q32 Bio Inc. (QTTB) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track QTTB biotech catalysts?→
Add QTTB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Q32 Bio Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.